Is a complete NUVB research report available?

No complete published report is available for Nuvation Bio Inc. (NUVB) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Nuvation Bio Inc. (NUVB)

NYSE: NUVB · USD

$6.59

-0.10 (-1.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first NUVB analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2.3B
Revenue (ttm)	143M
Net income (ttm)	-146M
EPS (ttm)	-$0.42
Shares out	348.2M
Volume	6,883,199
Beta	1.53
Price target	$12.3	+87.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 143M
Net income (ttm): -146M
EPS (ttm): -$0.42
Market cap: 2.3B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All NUVB indicators

Market & fundamental data

Available fields

213

Groups with data

Currency

USD

Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001811063
Company name	Nuvation Bio Inc.
Country	United States
Country code	US
Cusip	67080N101
Employees	307
Employees Change	34%
Employees Change Percent	12.45
Enterprise value	$2B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US67080N1019
Last refreshed	2026-07-30
Market cap	$2.3B
Market cap category	Mid-Cap
Price	$6.59
Price currency	USD
Rev Per Employee	465,947.88x
Sector	Healthcare
Sector PE	45.63
Sector PE Fwd	24.38
Sic	2834
Symbol	NUVB
Website	https://www.nuvationbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.36%
EV Sales Forward	10.46x
EV/Sales	13.83x
FCF yield	-5.49%
P/B ratio	7.17x
P/S ratio	16.04x
PS Forward	12.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-104.99%
EBITDA Margin	-103.61%
Gross margin	90.78%
Gross Profit	$129.9M
Gross Profit Growth	7,174.57%
Gross Profit Growth Q	7,701.72%
Net Income	$-146M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-102.06%
Profit Margin	-102.06%
Profit Per Employee	$-475,550
Profitable Quarters	$1
ROA	-17.02
Roa5y	-14.53
ROCE	-28.3
ROE	-39.51
Roe5y	-40.89
ROIC	-19.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	158.6%
Cagr3y	55.56%
Cagr5y	-5.32%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth	1,205.52x
Revenue Growth Q	2,598.7x
Revenue Growth Quarters	4x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.26
Assets	$610.2M
Cash	$533.7M
Current Assets	$591.5M
Current Liabilities	$79.5M
Debt	$217M
Debt Equity	$0.68
Equity	$319.6M
Interest Coverage	-7.38
Liabilities	$290.7M
Long Term Assets	$18.7M
Long Term Liabilities	$211.2M
Net Cash	$316.7M
Net Cash By Market Cap	$13.8
Net Cash Growth	-29.65%
Net Debt Equity	$-0.99
Tangible Book Value	$308.8M
Tangible Book Value Per Share	$0.89
WACC	12.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.44
Inventory Turnover	1.66
Net Working Capital	$-6.2M
Quick ratio	7.04
Working Capital	$512M
Working Capital Turnover	$0.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-15.09%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	158.43%
200-day SMA	5.67
3Y total return	276.57%
50-day SMA	5.47
50-day SMA vs 200-day SMA	50under200
5Y total return	-23.9%
All Time High	15.23
All Time High Change	-56.73%
All Time High Date	2021-05-26
All Time Low	0.95
All Time Low Change	593.68%
All Time Low Date	2023-10-31
ATR	0.4
Beta	1.53
Beta1y	1.54
Beta2y	1.68
Ch YTD	-26.45
High	6.77
High52	9.75
High52 Date	2025-12-22
High52ch	-32.41%
Low	6.39
Low52	2.18
Low52 Date	2025-08-11
Low52ch	202.29%
Ma50ch	20.5%
Premarket Change Percent	-0.45
Premarket Price	$6.66
Premarket Volume	14,765
Price vs 200-day SMA	16.16%
RSI	63.9
RSI Monthly	59.9
RSI Weekly	63.38
Sharpe ratio	1.45x
Sortino ratio	2.62
Total Return	-15.09%
Tr YTD	-26.45
Tr1m	16.64%
Tr1w	0.61%
Tr3m	44.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	7
Analyst Price Target Top	$15
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.13
Earnings Revenue Estimate	27,541,840x
Earnings Revenue Estimate Growth	469.87x
Operating Income	$-150.2M
Operating margin	-105
Price target	$12.33
Price Target Change	$87.1
Price Target Change Top	$128

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	254,614,405%
Float Percent	73.12%
Net Borrowing	197,380,000
Shares Insiders	19.42%
Shares Institutions	56.42%
Shares Out	348,201,971
Shares Qo Q	0.87%
Shares Yo Y	15.09%
Short Float	21.86%
Short Ratio	6.13
Short Shares	15.99

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-163.1M
Adjusted OCF	-162,804,000
Average Volume	6,607,109.5x
Bv Per Share	0.92
CAPEX	$-330,000
Ch1m	16.64
Ch1w	0.61
Ch1y	158.4
Ch3m	44.52
Ch3y	276.6
Ch5y	-23.9
Ch6m	24.34
Change	-1.49%
Change From Open	-0.75
Close	6.69
Days Gap	-0.75
Depreciation Amortization	1,965,000
Dollar Volume	45,360,281.4
Earnings Date	2026-08-06
Earnings Time	bmo
EBIT	$-150.2M
EBITDA	$-148.2M
EPS	$-0.42
F Score	3
FCF	$-126.1M
FCF EV Yield	-6.37x
FCF Per Share	$-0.36
Financing CF	202,031,000
Fiscal Year End	December
Founded	2,018
Investing CF	1,702,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-02
Ma150	5.53
Ma150ch	19.25%
Ma20	6.06
Ma20ch	8.67%
Net CF	77,414,000
Next Earnings Date	2026-08-06
Open	6.64
Optionable	Yes
Position In Range	52.63
Post Close	6.59
Postmarket Change Percent	-0.15
Postmarket Price	$6.58
Ppne	4,133,000
Pre Close	6.69
Price Date	2026-07-29
Ptbv Ratio	7.43
Relative Volume	1.04x
Revenue	143,046,000x
SBC By Revenue	25.92x
Share Based Comp	37,073,000
Tr6m	24.34%
Us State	New York
Volume	6,883,199
Z Score	0.81

Nuvation Bio Inc. (NUVB)

Coverage state: Market snapshot only — no published research

Generate the first NUVB analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · NUVB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NUVB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NUVB

Frequently asked questions